The defense against a mosquito-borne viral disease that has spread to over 125 countries and is one of the World Health Organization's top threats to global health expanded today in Brazil.
An innovative Dengue vaccine that does not require pre-vaccination testing was approved by the National Health Surveillance Agency (ANVISA) to prevent dengue in Brazil caused by any of the four virus serotypes.
Innovative Dengue Vaccine Gains Another Approval
Europe's Bird Flu Outbreak Raises Concerns
Since late 2021, a global shift has occurred in the ecology of highly pathogenic avian influenza (HPAI) of the H5 subtype. The continual spread of H5 HPAI (bird flu) is cause for concern, given the high mortality in birds, mammals, and some humans.